Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2013
02/28/2013CA2845854A1 C-halogen bond formation
02/28/2013CA2845578A1 Pyrimidine pde10 inhibitors
02/27/2013EP2562174A1 Herbicidal 6-Oxo-1,6-dihydropyrimidin-5-carboxamides and 2-Oxo-1,2-dihydropyridin-3-carboxamides
02/27/2013EP2562168A1 Therapeutic piperazines as PDE4 inhibitors
02/27/2013EP2562167A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562165A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562161A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562160A1 Therapeutic agent or preventive agent for urine collection disorder
02/27/2013EP2561874A2 Pharmaceutical compositions for treating cancer
02/27/2013EP2561871A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
02/27/2013EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
02/27/2013EP2560966A2 Multisubstituted aromatic compounds as inhibitors of thrombin
02/27/2013EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors
02/27/2013EP2560955A2 Novel benzamide derivatives
02/27/2013EP2560953A2 Novel inhibitors
02/27/2013EP2560653A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
02/27/2013EP2560652A2 Anti-viral compounds
02/27/2013EP2560488A1 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
02/27/2013EP2143444A9 Compositions for inhibition of angiogenesis
02/27/2013CN102947415A Organic electronic devices comprising a layer of a pyridine compound and a 8-hydroxyquinolinolato earth alkaline metal, or alkali metal complex
02/27/2013CN102947293A Triazole-substituted anthranilic acid amides as pesticides
02/27/2013CN102947292A Nitrogen containing heteroaryl compounds
02/27/2013CN102947291A Prodrug of triazolone compound
02/27/2013CN102947290A Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
02/27/2013CN102947289A Arylethynyl derivatives
02/27/2013CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2013CN102947275A Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
02/27/2013CN102947274A Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
02/27/2013CN102946881A Anti-viral compounds
02/27/2013CN102942558A Preparation method of benzazepine derivatives
02/27/2013CN102942557A Novel medicinal salt of dexlansoprazole
02/27/2013CN102942556A Preparation technique of alogliptin benzoate
02/27/2013CN102942529A 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound
02/27/2013CN102942431A Method for separating chiral compound by using molecular sieves
02/27/2013CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts
02/27/2013CN102002035B Delta and epsilon crystal forms of imatinib mesylate
02/27/2013CN101987843B Method for synthesizing halofuginone hydrobromide and analogues thereof
02/27/2013CN101962379B Method for refining sulfonyl isoquinoline derivative
02/27/2013CN101827828B 1, 2, 4 -triazole derivatives as serotonergic modulators
02/27/2013CN101824033B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
02/27/2013CN101687851B Organic compounds
02/27/2013CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
02/27/2013CN101511800B Triazolyl phenyl benzenesulfonamides
02/27/2013CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
02/26/2013US8383814 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
02/26/2013US8383666 Pyrrole derivatives, preparation of same and therapeutic application thereof
02/26/2013US8383660 Dibenzyl amine compounds and derivatives
02/26/2013US8383651 Compounds which selectively modulate the CB2 receptor
02/26/2013US8383650 Organic compounds
02/26/2013US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery
02/26/2013US8383646 Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
02/26/2013US8383642 Spiropiperidine compounds
02/26/2013US8383638 Aminobenzoquinazolinone M1 receptor positive allosteric modulators
02/26/2013US8383637 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
02/26/2013US8383629 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
02/26/2013US8383628 Pyridyl derivatives and their use as therapeutic agents
02/26/2013US8383616 Aryl isoxazole compounds with antitumoural activities
02/26/2013CA2608468C Tri-, tetra-substituted-3-aminopyrrolidine derivative
02/26/2013CA2572544C Modified pyrimidine glucocorticoid receptor modulators
02/26/2013CA2571527C Piperazinediones as oxytocin receptor antagonists
02/26/2013CA2523426C Aza spiro alkane derivatives as inhibitors of metalloproteases
02/21/2013WO2013025733A1 Lysophosphatidic acid receptor antagonists
02/21/2013WO2013024898A1 Heterocyclic derivative and pharmaceutical drug
02/21/2013WO2013024394A1 Novel reference markers of dabigatran etexilate
02/21/2013WO2013024384A1 Improved process for preparation of dabigatran etexilate and its novel intermediate
02/21/2013WO2013024358A2 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors
02/21/2013WO2013024171A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
02/21/2013WO2013024170A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
02/21/2013WO2013024078A1 Inhibitors of bruton's tyrosine kinase
02/21/2013WO2013024010A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2013024009A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2013024008A1 Aniline type compounds
02/21/2013WO2013024007A1 Process for preparing n-substituted 1h-pyrazole-5-carbonylchloride compounds
02/21/2013WO2013024006A1 Anthranilamide compounds and their use as pesticides
02/21/2013WO2013024005A1 Anthranilamide compounds and their use as pesticides
02/21/2013WO2013024004A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2013024003A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2013023795A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
02/21/2013WO2012149186A9 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
02/21/2013WO2012026897A9 A process for the preparation of imatinib base
02/21/2013WO2012022120A8 Dihydropyrazole compounds
02/21/2013US20130046095 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
02/21/2013US20130045994 Pyridine derivative
02/21/2013US20130045992 Compositions and Methods for Enhancing Proteasome Activity
02/21/2013US20130045986 Novel compounds as modulators of gpr-119
02/21/2013US20130045977 TGF-beta SIGNAL TRANSDUCTION INHIBITOR
02/21/2013US20130045976 Isoindoline compounds and methods of their use
02/21/2013US20130045975 Bicyclic heteroaryl inhibitors of pde4
02/21/2013US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
02/21/2013US20130045972 Glucocorticoid receptor antagonists
02/21/2013US20130045965 Inhibitors of bruton's tyrosine kinase
02/21/2013US20130045962 Peptide deformylase inhibitors
02/21/2013US20130045955 Novel compounds
02/21/2013US20130043460 Carbazole serial compounds
02/21/2013US20130043137 Novel compound and use thereof
02/21/2013DE102010023959B4 Neue Verbindungen als Liganden für Übergangsmetallkomplexe und daraus hergestellte Materialien, sowie Verwendung dazu New compounds as ligands for transition metal complexes and derived materials, and use this
02/21/2013CA2845477A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
02/21/2013CA2845284A1 Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors
02/21/2013CA2844982A1 Lysophosphatidic acid receptor antagonists
02/21/2013CA2844794A1 Heterocyclic derivative and pharmaceutical